Latest News
OS Therapies Incorporated
- Maryland's OS Therapies Raises $7.2 Million to Advance Osteosarcoma Immunotherapy Toward Regulatory Review
- OS Therapies raises $7.2M via warrant deal to fund cancer drug filings
- OS Therapies Announces Initial Closing of Warrant Exercise Inducement and Exchange Offer for Initial Gross Proceeds of Approximately $7.2 Million
- OS Therapies appoints Rubenstein PR to lead glo...
- A dog cancer treatment could launch in the U.S. in 2027, OS Therapies hopes
- OS Therapies Reports Significant Three-Year Survival Data for Bone Cancer Treatment
- OS Therapies, Inc. Announces Appointment of Kerry Clem as Chief Commercial Officer, Effective September 29, 2026
- WHO approves 'Herlystic' as brand name for OS T...
Headlines from the last 30 days, linking to the original publishers. See all market news →